Option Care Health (NASDAQ:OPCH) Trading 4.5% Higher – Should You Buy?

Option Care Health, Inc. (NASDAQ:OPCH)’s share price traded up 4.5% during mid-day trading on Wednesday . The stock traded as high as $24.88 and last traded at $24.58. Approximately 2,180,041 shares traded hands during mid-day trading, a decline of 11% from the average session volume of 2,449,761 shares. The stock had previously closed at $23.52.

Analysts Set New Price Targets

Several brokerages have weighed in on OPCH. Stephens reissued an “equal weight” rating and set a $24.00 price objective (down from $30.00) on shares of Option Care Health in a report on Friday, July 17th. UBS Group reaffirmed a “buy” rating on shares of Option Care Health in a research note on Tuesday, June 16th. Zacks Research raised shares of Option Care Health from a “strong sell” rating to a “hold” rating in a research note on Monday, July 6th. The Goldman Sachs Group initiated coverage on shares of Option Care Health in a report on Monday, June 8th. They issued a “neutral” rating and a $22.00 price objective on the stock. Finally, Wall Street Zen raised shares of Option Care Health from a “hold” rating to a “buy” rating in a research note on Saturday, August 1st. Seven research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat.com, Option Care Health has an average rating of “Moderate Buy” and a consensus price target of $29.92.

Option Care Health Stock Up 4.0%

The company has a debt-to-equity ratio of 0.91, a current ratio of 1.47 and a quick ratio of 0.98. The stock has a market cap of $3.67 billion, a price-to-earnings ratio of 18.40, a price-to-earnings-growth ratio of 1.39 and a beta of 0.61. The firm has a 50 day simple moving average of $23.12 and a two-hundred day simple moving average of $24.23.

Option Care Health (NASDAQ:OPCH) last posted its earnings results on Wednesday, July 29th. The company reported $0.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.43 by $0.02. The company had revenue of $1.44 billion during the quarter, compared to analyst estimates of $1.42 billion. Option Care Health had a return on equity of 18.74% and a net margin of 3.68%.The company’s revenue for the quarter was up 1.9% compared to the same quarter last year. During the same period in the previous year, the company earned $0.41 EPS. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. As a group, sell-side analysts expect that Option Care Health, Inc. will post 1.69 EPS for the current year.

Institutional Investors Weigh In On Option Care Health

Several large investors have recently bought and sold shares of the company. Engineers Gate Manager LP lifted its stake in Option Care Health by 263.0% in the second quarter. Engineers Gate Manager LP now owns 43,560 shares of the company’s stock valued at $913,000 after buying an additional 31,561 shares in the last quarter. Squarepoint Ops LLC increased its position in shares of Option Care Health by 234.1% during the second quarter. Squarepoint Ops LLC now owns 434,408 shares of the company’s stock worth $9,110,000 after acquiring an additional 304,376 shares in the last quarter. Empirical Finance LLC acquired a new stake in shares of Option Care Health during the second quarter worth $595,000. Nykredit A S acquired a new stake in shares of Option Care Health during the second quarter worth $56,000. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in Option Care Health in the 2nd quarter valued at $544,000. Institutional investors own 98.05% of the company’s stock.

About Option Care Health

Option Care Health, Inc is a provider of home and alternate-site infusion services in the United States. The company works with patients, physicians, hospitals, health plans and pharmaceutical manufacturers to deliver infusion therapy outside traditional hospital settings, including in patients’ homes, ambulatory infusion centers and other outpatient locations.

Its services include pharmacy and nursing support for intravenous and subcutaneous therapies, care coordination, patient education, clinical monitoring and reimbursement assistance.